Shadow validation happens when governance is unclear
Teams want to move fast, so they create their own templates, run their own tests, and store evidence wherever they can. The intention is good. The outcome is inconsistent control and weak retrievability.
How the governance gap shows up
Multiple templates. Impact assessments and test scripts look different across teams.
Inconsistent approvals. Review steps vary, and evidence is hard to defend.
Scattered artifacts. Proof lives in emails, personal drives, and chat threads.
How to close the gap
Define standard templates, enforce evidence indexing, and run a calendar-based operating rhythm for key controls. Governance is not a blocker. It is the operating system that keeps speed and compliance aligned.
In recent years, validation processes across the pharmaceutical industry have been undergoing a major transformation. Workflows that were traditionally managed through paper documentation, spreadsheets and manual review cycles are increasingly moving toward digital validation platforms. As a result, life sciences organizations often evaluate solutions such as Kneat, Validfor, ValGenesis, MasterControl and Veeva when modernizing validation lifecycle management and compliance documentation.
